Total Payments
$688.26
2023 Payments
$471.29
Companies
7
Transactions
34
Medicare Patients
3,012
Medicare Billing
$337,179
Payment Breakdown by Category
Food & Beverage$673.68 (97.9%)
Education$14.58 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $673.68 | 33 | 97.9% |
| Education | $14.58 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $236.63 | 18 | $0 (2023) |
| AbbVie Inc. | $202.58 | 8 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $119.03 | 1 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $75.25 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $23.42 | 1 | $0 (2023) |
| Sandoz Inc. | $17.66 | 1 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $13.69 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $471.29 | 24 | Celgene Corporation ($185.61) |
| 2022 | $62.94 | 4 | Celgene Corporation ($51.02) |
| 2020 | $13.69 | 1 | IRONWOOD PHARMACEUTICALS, INC ($13.69) |
| 2019 | $25.83 | 2 | AbbVie, Inc. ($25.83) |
| 2017 | $114.51 | 3 | AbbVie, Inc. ($114.51) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $6.20 | General |
| Category: Neuroscience | ||||||
| 10/31/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.53 | General |
| Category: Neuroscience | ||||||
| 09/07/2023 | Sandoz Inc. | HYRIMOZ (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Gastroenterology | ||||||
| 08/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Gastroenterology | ||||||
| 08/14/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $9.19 | General |
| Category: Neuroscience | ||||||
| 08/12/2023 | AbbVie Inc. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.30 | General |
| Category: Neuroscience | ||||||
| 07/26/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $7.09 | General |
| Category: Neuroscience | ||||||
| 07/25/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $11.99 | General |
| Category: Neuroscience | ||||||
| 07/10/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.74 | General |
| Category: Neuroscience | ||||||
| 07/05/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.95 | General |
| Category: Neuroscience | ||||||
| 06/20/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.65 | General |
| Category: Neuroscience | ||||||
| 06/14/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: Neuroscience | ||||||
| 06/13/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.13 | General |
| Category: Neuroscience | ||||||
| 06/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Gastroenterology | ||||||
| 06/07/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.56 | General |
| Category: Neuroscience | ||||||
| 05/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Gastroenterology | ||||||
| 05/18/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $119.03 | General |
| Category: Neuroscience | ||||||
| 05/16/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.16 | General |
| Category: Neuroscience | ||||||
| 05/15/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $5.52 | General |
| Category: Neuroscience | ||||||
| 03/23/2023 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $5.89 | General |
| 03/21/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: IMMUNOLOGY | ||||||
| 01/11/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/21/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.96 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 672 | 740 | $480,097 | $77,647 |
| 2022 | 20 | 713 | 758 | $452,793 | $65,946 |
| 2021 | 19 | 889 | 972 | $594,010 | $101,589 |
| 2020 | 18 | 738 | 807 | $488,444 | $91,998 |
Total Patients
3,012
Total Services
3,277
Medicare Billing
$337,179
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 70 | 71 | $106,997 | $15,212 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 133 | $30,457 | $12,427 | 40.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 34 | 34 | $45,424 | $8,032 | 17.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 19 | 19 | $28,633 | $7,699 | 26.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 101 | 101 | $134,936 | $7,618 | 5.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $17,591 | $5,740 | 32.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 40 | $17,240 | $5,654 | 32.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 50 | $10,900 | $4,894 | 44.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 52 | 53 | $51,728 | $4,064 | 7.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 14 | 14 | $13,664 | $2,739 | 20.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 13 | $11,011 | $1,218 | 11.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $3,245 | $1,160 | 35.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 43 | 49 | $980.00 | $411.60 | 42.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 25 | 30 | $1,200 | $228.30 | 19.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 18 | 19 | $1,045 | $196.65 | 18.8% |
| 83550 | Iron binding capacity | Office | 2023 | 13 | 17 | $765.00 | $145.69 | 19.0% |
| 83540 | Iron level | Office | 2023 | 13 | 17 | $561.00 | $107.78 | 19.2% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 20 | 20 | $3,720 | $98.57 | 2.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 67 | 67 | $100,969 | $14,351 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 118 | $27,022 | $11,348 | 42.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 113 | 113 | $150,968 | $9,526 | 6.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 67 | 67 | $24,053 | $8,577 | 35.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 42 | $18,102 | $6,681 | 36.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 59 | 61 | $59,536 | $4,034 | 6.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 29 | $6,322 | $2,449 | 38.7% |
About Dr. Niraj Ajmere, M.D
Dr. Niraj Ajmere, M.D is a Gastroenterology healthcare provider based in Lisle, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558309856.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niraj Ajmere, M.D has received a total of $688.26 in payments from pharmaceutical and medical device companies, with $471.29 received in 2023. These payments were reported across 34 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($673.68).
As a Medicare-enrolled provider, Ajmere has provided services to 3,012 Medicare beneficiaries, totaling 3,277 services with total Medicare billing of $337,179. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Lisle, IL
- Active Since 06/02/2006
- Last Updated 01/14/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1558309856
Products in Payments
- ZEPOSIA (Drug) $349.77
- XIFAXAN (Drug) $53.42
- RINVOQ (Biological) $28.95
- DIFICID (Drug) $23.42
- Humira (Biological) $22.26
- TRULANCE (Drug) $21.83
- SKYRIZI (Biological) $21.37
- HYRIMOZ (Drug) $17.66
- Linzess (Drug) $13.69
- HUMIRA (Biological) $11.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.